These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18066130)
1. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype. Numa AM; Abbott FS; Chang TK Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130 [TBL] [Abstract][Full Text] [Related]
2. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype. Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols. Lau AJ; Chang TK Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249 [TBL] [Abstract][Full Text] [Related]
4. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1. Chang TK; Chen J; Yeung EY Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778 [TBL] [Abstract][Full Text] [Related]
5. Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid. Sadeque AJ; Fisher MB; Korzekwa KR; Gonzalez FJ; Rettie AE J Pharmacol Exp Ther; 1997 Nov; 283(2):698-703. PubMed ID: 9353388 [TBL] [Abstract][Full Text] [Related]
6. Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes. Ho PC; Abbott FS; Zanger UM; Chang TK Pharmacogenomics J; 2003; 3(6):335-42. PubMed ID: 14597963 [TBL] [Abstract][Full Text] [Related]
7. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols. Kuo If; Chen J; Chang TK Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306 [TBL] [Abstract][Full Text] [Related]
8. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients. Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ginkgo biloba extract as an activator of human glucocorticoid receptor. Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK J Ethnopharmacol; 2013 Jan; 145(2):670-5. PubMed ID: 23220176 [TBL] [Abstract][Full Text] [Related]
10. Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients. Amini-Shirazi N; Ghahremani MH; Ahmadkhaniha R; Mandegary A; Dadgar A; Abdollahi M; Shadnia S; Pakdaman H; Kebriaeezadeh A Toxicol Mech Methods; 2010 Oct; 20(8):452-7. PubMed ID: 20602621 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of human cytochromes P450 by components of Ginkgo biloba. von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849 [TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Mohutsky MA; Anderson GD; Miller JW; Elmer GW Am J Ther; 2006; 13(1):24-31. PubMed ID: 16428919 [TBL] [Abstract][Full Text] [Related]
13. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes. Chang TK; Chen J; Teng XW Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids. Mohamed MF; Frye RF Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883 [TBL] [Abstract][Full Text] [Related]
15. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells. Rajaraman G; Yang G; Chen J; Chang TK Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518 [TBL] [Abstract][Full Text] [Related]
16. Ginkgolide A contributes to the potentiation of acetaminophen toxicity by Ginkgo biloba extract in primary cultures of rat hepatocytes. Rajaraman G; Chen J; Chang TK Toxicol Appl Pharmacol; 2006 Dec; 217(2):225-33. PubMed ID: 17045319 [TBL] [Abstract][Full Text] [Related]
17. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats. Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034 [TBL] [Abstract][Full Text] [Related]
18. P450-catalyzed in-chain desaturation of valproic acid: isoform selectivity and mechanism of formation of Delta 3-valproic acid generated by baculovirus-expressed CYP3A1. Fisher MB; Thompson SJ; Ribeiro V; Lechner MC; Rettie AE Arch Biochem Biophys; 1998 Aug; 356(1):63-70. PubMed ID: 9681992 [TBL] [Abstract][Full Text] [Related]
19. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. van Beek TA; Montoro P J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661 [TBL] [Abstract][Full Text] [Related]
20. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]